Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-11 | New | $96,130,465 | Unknown | Equity Only | SEC link | |
| 2022-03-22 | New | $4,000,000 | $4,000,000 | Debt Only | 06b | SEC link |
| 2022-03-09 | New | $2,000,000 | $2,000,000 | Debt Only | 06b | SEC link |
| 2019-11-18 | Amended | $42,514,946 | $15,000,000 | Equity Only | 06b | SEC link |
| 2019-03-13 | New | $27,514,946 | $27,514,946 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Steve Anheier | Executive |
| Doug Godshall | Director, Executive |
| Seth Harrison | Director |
| David Lewis | Director |
| David Mc Intyre | Director |
| Antoine Papiernik | Director |
| Zack Scott | Director |
| Jonathan Waldstreicher | Executive |